A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
To evaluate the efficacy of surufatinib combined with camrelizumab, nab-paclitaxel, and gemcitabine versus nab-paclitaxel plus gemcitabine as the first-line treatment in metastatic pancreatic cancer
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-75 lat
- •Potwierdzony rak trzustki (badanie patologiczne)
- •Rak trzustki z przerzutami do innych organów (stadium IV)
- •Brak wcześniejszego leczenia tego stadium nowotworu
- •Co najmniej jedno widoczne ognisko nowotworu
- •Dobry ogólny stan zdrowia (skala ECOG 0-1)
- •Spodziewany czas przeżycia co najmniej 12 tygodni
- •Pełna świadomość i chęć uczestnictwa w badaniu
✗ Disqualifies
- •Alergia na którykolwiek z badanych leków
- •Inne nowotwory w ciągu ostatnich 5 lat
- •Poważna operacja mniej niż 4 tygodnie temu
- •Radioterapia mniej niż 1-4 tygodnie temu
- •Nieskontrolowane wysokie ciśnienie krwi
- •Choroby wątroby (w tym wirusowe zapalenie wątroby)
- •Stosowanie leków osłabiających odporność w ciągu 4 tygodni
- •Stosowanie innych leków immunoterapii w ciągu 2 tygodni
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- September 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (52)
Anhui Provincial Hospital
Hefei, China
Beijing Cancer Hospital
Beijing, China
Peking Union Medical College Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
Chongqing General Hospital
Chongqing, China
Chongqing University Cancer Hospital
Chongqing, China
Fujian Cancer Hospital
Fuzhou, China
The First Affiliated Hospital of Xiamen University
Xiamen, China
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, China
Guangdong Provincial People's Hospital
Guandong, China
Hainan General Hospital
Haikou, China
First Hospital of Qinhuangdao
Qinhuangdao, China
Harbin Medical University Cancer Hospital
Harbin, China
Anyang Cancer Hospital
Anyang, China
The First Affiliated Hospital of Henan Medical University
Xinxiang, China
Henan Cancer Hospital
Zhengzhou, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Hubei Cancer Hospital
Wuhan, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Hunan Cancer Hospital
Changsha, China
XiangYa Hospital CentralSouth University
Changsha, China
Jiangsu Cancer Hospital
Nanjing, China
Nanjing Drum Tower Hospital
Nanjing, China
Nanjing Tianyinshan Hospital
Nanjing, China
Nantong Cancer Hospital
Nantong, China
The First Affiliated Hospital of Soochow University
Suzhou, China
Jiangyin People's Hospital
Wuxi, China
Jiangxi Cancer Hospital
Nanchang, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
Jilin Cancer Hospital
Changchun, China
Liaoning Cancer Hospital
Shenyang, China
The First Hospital of China Medical University
Shenyang, China
Shandong Cancer Hospital
Jinan, China
Affiliated Hospital Of Jining Medical University
Jining, China
Linyi People's Hospital
Linyi, China
Huashan Hospital, Fudan University
Shanghai, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
ZhongShan Hospital Fudan University
Shanghai, China
Shanxi Provincial Cancer Hospitial
Taiyuan, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, China
Sichuan Cancer Hospital
Chengdu, China
West China Hospital of Sichuan University
Chengdu, China
Tianjin Cancer Hospital Airport Hospital
Tianjin, China
Tianjin Cancer Hospital
Tianjin, China
Yunnan Cancer Hospital
Kunming, China
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
Zhejiang Cancer Hospital
Hangzhou, China
Zhejiang Provincial People's Hospital
Hangzhou, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
Trial contact
Panfeng Tan
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.